INNOVITAL SYSTEMS INC — Department of Defense SBIR Phase II: DHA213-003

INNOVITAL SYSTEMS INC — SBIR Phase II award from Department of Defense.

Amount
$1,099,930
Agency
Department of Defense · Defense Health Program
Program / Phase
SBIR · Phase II
Topic
DHA213-003
Solicitation
21.3
NAICS
Place of performance
MD
Period
2023-02-07 → 2025-06-30

Description

Future, multi-domain operational environments will require tools and systems that decrease the skill and experience level required to correctly perform critical patient care procedures, including airway management. Building upon extensive experience with device development for the combat medic, InnoVital Systems proposes to develop the Next-Generation Nasopharyngeal Airway (NPA), a universal device with intra-procedural guidance that facilitates placement to the correct depth and an adaptable design that maximizes ventilation, prevents NPA collapse, and facilitates securement to a patient. The design also enables optimized positive pressure delivery and is compatible with advanced pre-hospital monitoring techniques. In the Phase II effort, the NPA design will be iteratively refined, prototyped, and tested to demonstrate safety, effectiveness, and usability, such that regulatory data requirements are satisfied and full productization will be complete, including production level manufacturing, packaging, and labeling. Our specific experience with the development of procedural aids (including for airway management) for pre-hospital and acute care providers and existing relationships with relevant industry partners puts InnoVital in the best position for delivering a useful and marketable medical device.